128 related articles for article (PubMed ID: 15998657)
21. Single daily dose administration of cyclosporine in renal transplant recipients.
Halim MA; Said T; Al-Otaibi T; Eleawa S; Al-Maged H; Gawish AE; Nair P; Al-Muzairai I; Nampoory MR; Al-Mousawi M
Transplant Proc; 2007 May; 39(4):1225-7. PubMed ID: 17524939
[TBL] [Abstract][Full Text] [Related]
22. Effect of vitamin E and selenium supplementation on oxidative stress status in pulmonary tuberculosis patients.
Seyedrezazadeh E; Ostadrahimi A; Mahboob S; Assadi Y; Ghaemmagami J; Pourmogaddam M
Respirology; 2008 Mar; 13(2):294-8. PubMed ID: 18339032
[TBL] [Abstract][Full Text] [Related]
23. Three-years experience with Neoral C2 monitoring adjusted to a target range of 500-600 ng/ml in long-term renal transplant recipients receiving dual immunosuppressive therapy.
Carstens J
Scand J Urol Nephrol; 2008; 42(3):286-92. PubMed ID: 18432535
[TBL] [Abstract][Full Text] [Related]
24. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
Rodríguez E; Delucchi MA; Cano F; Valdebenito S; Castillo MC; Villegas R
Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
[TBL] [Abstract][Full Text] [Related]
25. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus].
Peng LK; Xie XB; Peng FH; Wang Y; Jiang Y; Lan GB; Fang CH; Nie MH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):59-62. PubMed ID: 17344588
[TBL] [Abstract][Full Text] [Related]
26. Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus.
Bäckman L; Reisaeter AV; Wramner L; Ericzon BG; Salmela K; Brattström C
Clin Transplant; 2006; 20(3):336-9. PubMed ID: 16824151
[TBL] [Abstract][Full Text] [Related]
27. Reversal of loss of glomerular filtration rate in children with transplant nephropathy after switch to everolimus and low-dose cyclosporine A.
Pape L; Ahlenstiel T; Ehrich JH; Offner G
Pediatr Transplant; 2007 May; 11(3):291-5. PubMed ID: 17430485
[TBL] [Abstract][Full Text] [Related]
28. Influence of an antioxidant vitamin-enriched drink on pre- and post-exercise lymphocyte antioxidant system.
Sureda A; Tauler P; Aguiló A; Cases N; Llompart I; Tur JA; Pons A
Ann Nutr Metab; 2008; 52(3):233-40. PubMed ID: 18562790
[TBL] [Abstract][Full Text] [Related]
29. Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients.
Schweiger M; Wasler A; Prenner G; Stiegler P; Stadlbauer V; Schwarz M; Tscheliessnigg K
Transpl Immunol; 2006 Jun; 16(1):46-51. PubMed ID: 16701176
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine-A-based immunosuppression and renal functional reserve in organ-transplant patients.
Kamar N; Allard J; Ader JL; Rostaing L
Transplant Proc; 2004 Mar; 36(2 Suppl):248S-250S. PubMed ID: 15041347
[TBL] [Abstract][Full Text] [Related]
31. Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppression.
Sommerer C; Giese T; Schmidt J; Meuer S; Zeier M
Transplantation; 2008 Jan; 85(1):15-21. PubMed ID: 18192906
[TBL] [Abstract][Full Text] [Related]
32. Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients.
Falck P; Asberg A; Guldseth H; Bremer S; Akhlaghi F; Reubsaet JL; Pfeffer P; Hartmann A; Midtvedt K
Transplantation; 2008 Jan; 85(2):179-84. PubMed ID: 18212621
[TBL] [Abstract][Full Text] [Related]
33. Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension.
Rodrigo R; Prat H; Passalacqua W; Araya J; Bächler JP
Clin Sci (Lond); 2008 May; 114(10):625-34. PubMed ID: 17999638
[TBL] [Abstract][Full Text] [Related]
34. Antioxidant supplementation enhances antioxidant capacity and mitigates oxidative damage following acute ischaemic stroke.
Ullegaddi R; Powers HJ; Gariballa SE
Eur J Clin Nutr; 2005 Dec; 59(12):1367-73. PubMed ID: 16091766
[TBL] [Abstract][Full Text] [Related]
35. Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients.
Ross H; Pflugfelder P; Haddad H; Cantarovich M; White M; Ignaszewski A; Howlett J; Vaillancourt M; Dorent R; Burton JR;
J Heart Lung Transplant; 2008 Feb; 27(2):197-202. PubMed ID: 18267227
[TBL] [Abstract][Full Text] [Related]
36. Impact of cyclosporine A on magnesium homeostasis: clinical observation in lung transplant recipients and experimental study in mice.
Sabbagh F; El Tawil Z; Lecerf F; Hulin A; Maurois P; Dartevelle P; Bac P; German-Fattal M
Transplantation; 2008 Aug; 86(3):436-44. PubMed ID: 18698248
[TBL] [Abstract][Full Text] [Related]
37. Association between cyclosporine concentrations at 2 hours post-dose and clinical outcomes in de novo lung transplant recipients.
Akhlaghi F; Gonzalez L; Trull AK
J Heart Lung Transplant; 2005 Dec; 24(12):2120-8. PubMed ID: 16364860
[TBL] [Abstract][Full Text] [Related]
38. The effect of antioxidant supplementation on hepatitis C viral load, transaminases and oxidative status: a randomized trial among chronic hepatitis C virus-infected patients.
Groenbaek K; Friis H; Hansen M; Ring-Larsen H; Krarup HB
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):985-9. PubMed ID: 16894312
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of vitamin E and/or quercetin in attenuating chronic cyclosporine A-induced nephrotoxicity in male rats.
Zal F; Mostafavi-Pour Z; Vessal M
Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):720-4. PubMed ID: 17600547
[TBL] [Abstract][Full Text] [Related]
40. Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0.
Loichot C; Bentue-Ferrer D; Bernard N; Bonardet A; Boulieu R; Kergueris MF; Paintaud G; Peytavin G; Simon N; Marquet P;
Fundam Clin Pharmacol; 2006 Feb; 20(1):91-6. PubMed ID: 16448399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
